NATCO PHARMA LTD.: Company informed that that FMC Corporation and FMC Singapore have served a copy of appeal on Natco. The Appeal is against the well-reasoned and clear judgement of the Hon’ble High Court of Delhi dated 19th September, 2022 which enabled Natco to launch its CTPR (Chlorantraniliprole) products.
CTPR is out of patent now, many Indian players are launching CTPR (Best Agrolife is the first one to launch CTPR combinations in the market and many others ), then why still Natco is fighting with FMC ?
Can someone shed some light on this please ?
| Subscribe To Our Free Newsletter |
